Hans Meyer-Wonnay

Title: The Innovations of Hans Meyer-Wonnay

Introduction

Hans Meyer-Wonnay is a notable inventor based in Emmendingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to liquid pharmaceutical compositions. His work focuses on developing effective treatments for various cerebral diseases.

Latest Patents

Meyer-Wonnay holds a patent for a liquid pharmaceutical composition of a GABA analog. This composition includes at least one polyhydric alcohol containing 2 to 6 carbon atoms, with a pH ranging from about 5.5 to about 7.0. Additionally, he has described a two-component liquid pharmaceutical composition that consists of a first component, which is a powder mixture of a GABA analog and a solid polyhydric alcohol, and a second component that comprises a liquid base. His patent outlines methods for preparing these compositions and their application in treating cerebral diseases, including epilepsy, faintness attacks, neurodegenerative disorders, and various types of pain.

Career Highlights

Meyer-Wonnay is associated with Warner-Lambert Company, where he has been able to apply his expertise in pharmaceutical innovations. His work has led to advancements in the treatment of conditions such as anxiety, depression, and insomnia, showcasing his commitment to improving patient outcomes through innovative solutions.

Collaborations

Meyer-Wonnay has collaborated with talented individuals such as Neema Kulkarni and Michael Schneider. These partnerships have likely contributed to the development and refinement of his innovative pharmaceutical compositions.

Conclusion

Hans Meyer-Wonnay's contributions to the field of pharmaceuticals through his patent on liquid pharmaceutical compositions demonstrate his dedication to addressing complex medical challenges. His work continues to impact the treatment of various cerebral diseases, highlighting the importance of innovation in healthcare.